For research use only. Not for therapeutic Use.
GR 122222X(Cat No.:I028244)is an experimental compound investigated for its potential in treating neurological and psychiatric disorders. It functions as a selective antagonist of certain serotonin and dopamine receptors, particularly the 5-HT2A receptor. By modulating these neurotransmitter systems, GR 122222X has been studied for its ability to alleviate symptoms in conditions such as schizophrenia, anxiety, and depression. Preclinical studies suggest that it may have antipsychotic and anxiolytic properties without some of the side effects associated with other treatments. Ongoing research aims to assess its safety, efficacy, and therapeutic potential in clinical trials.
Catalog Number | I028244 |
CAS Number | 161161-54-2 |
Synonyms | GR 122222X; GR-122222X; GR122222X; |
Molecular Formula | C26H35N5O11S2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | [(2S)-2-[[(2S)-2-aminopropanoyl]-[(2R)-2-[[(2S)-3-hydroxy-2-[[(2S,3R)-3-hydroxypyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-sulfanylidenepropanoyl]amino]propanoyl] 3,5-dihydroxy-2-methyl-6-(sulfanylmethyl)benzoate |
InChI | InChI=1S/C26H35N5O11S2/c1-10-17(34)6-18(35)13(8-43)19(10)26(41)42-25(40)12(3)31(23(38)11(2)27)24(39)15(9-44)30-21(36)14(7-32)29-22(37)20-16(33)4-5-28-20/h6,9,11-12,14-16,20,28,32-35,43H,4-5,7-8,27H2,1-3H3,(H,29,37)(H,30,36)/t11-,12-,14-,15-,16+,20-/m0/s1 |
InChIKey | NKIYYTUDHBVJTH-UBOLUKANSA-N |
SMILES | CC1=C(C(=C(C=C1O)O)CS)C(=O)OC(=O)[C@H](C)N(C(=O)[C@H](C)N)C(=O)[C@H](C=S)NC(=O)[C@H](CO)NC(=O)[C@@H]2[C@@H](CCN2)O |